Bob Moser

89%
Flag icon
In October 2020, Emergent became one of four companies collaborating on a clinical trial for a combination treatment regimen that included Dr. Fauci’s drug remdesivir as a “background therapy.”
The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health
Rate this book
Clear rating
Open Preview